+499.5%
MRNA vs PSA
+7.3%
+492.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PSA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.0% | -1.5% |
| 7D | +5.5% | -3.7% | +9.1% | +7.9% |
| 30D | +158.7% | -7.7% | +166.5% | +172.4% |
| 3M | +182.1% | -0.6% | +182.7% | +182.9% |
| 6M | +151.8% | -0.9% | +152.7% | +153.3% |
| YTD | +393.6% | +18.7% | +374.9% | +348.5% |
| 1Y | +499.5% | +7.6% | +491.8% | +441.4% |
| All | +499.5% | +7.3% | +492.2% | +441.4% |
Cumulative growth
Daily Returns
Daily percentage return beside PSA.
Daily Out/Under-Performance
Portfolio return minus PSA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PSA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling